GSC
GOSS icon

Ground Swell Capital’s Gossamer Bio GOSS Stock Holding History

Ground Swell Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-125
Closed -$1.65K – 187
2026
Q2 		$1.65K Sell
125
-67
-35% -$1.5K ﹤0.01% 143
2026
Q1 		$5.04K Buy
+192
New +$24.1K 0.01% 113
2023
Q2 		– Sell
-168
Closed -$16.9K – 73
2023
Q1 		$16.9K Buy
+168
New +$25.7K 0.03% 44

Other funds holding GOSS

Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Worth Venture Partners
Worth Venture Partners Fort Lee, New Jersey $38.9M AUM 12.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
MB Generational Wealth
MB Generational Wealth Spokane, Washington $196M AUM 14.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Ground Swell Capital's GOSS Position: Q3 2026 in Review

Ground Swell Capital sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 125 shares — an estimated $1.65K sold.

Ground Swell Capital first reported a position in GOSS in Q1 2023 and held it in 3 quarters. The position peaked at $16.9K in Q1 2023. 37 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • Ground Swell Capital reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
  • Ground Swell Capital sold 125 Gossamer Bio shares in Q3 2026, an estimated $1.65K.
  • Ground Swell Capital first reported a position in Gossamer Bio in Q1 2023 and held it in 3 quarters.
  • Ground Swell Capital's Gossamer Bio position peaked at $16.9K in Q1 2023.
  • 37 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Ground Swell Capital's 13F filing for Q3 2026, filed 9 Nov 2026.